Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Metabotropic Glutamate Receptor (MRG) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 mGluR2
      • 1.3.3 mGluR4
      • 1.3.4 mGluR5
    • 1.4 Market Segment by Application
      • 1.4.1 Global Metabotropic Glutamate Receptor (MRG) Market Share by Application (2019-2025)
      • 1.4.2 Meningitis
      • 1.4.3 Septicemia
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Metabotropic Glutamate Receptor (MRG) Market Size
      • 2.1.1 Global Metabotropic Glutamate Receptor (MRG) Revenue 2014-2025
      • 2.1.2 Global Metabotropic Glutamate Receptor (MRG) Sales 2014-2025
    • 2.2 Metabotropic Glutamate Receptor (MRG) Growth Rate by Regions
      • 2.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales by Regions 2014-2019
      • 2.2.2 Global Metabotropic Glutamate Receptor (MRG) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Metabotropic Glutamate Receptor (MRG) Sales by Manufacturers
      • 3.1.1 Metabotropic Glutamate Receptor (MRG) Sales by Manufacturers 2014-2019
      • 3.1.2 Metabotropic Glutamate Receptor (MRG) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Metabotropic Glutamate Receptor (MRG) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Metabotropic Glutamate Receptor (MRG) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Metabotropic Glutamate Receptor (MRG) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Metabotropic Glutamate Receptor (MRG) Price by Manufacturers
    • 3.4 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Metabotropic Glutamate Receptor (MRG) Market
    • 3.6 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 mGluR2 Sales and Revenue (2014-2019)
      • 4.1.2 mGluR4 Sales and Revenue (2014-2019)
      • 4.1.3 mGluR5 Sales and Revenue (2014-2019)
    • 4.2 Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type
    • 4.3 Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Type
    • 4.4 Metabotropic Glutamate Receptor (MRG) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Metabotropic Glutamate Receptor (MRG) Sales by Application

    6 United States

    • 6.1 United States Metabotropic Glutamate Receptor (MRG) Breakdown Data by Company
    • 6.2 United States Metabotropic Glutamate Receptor (MRG) Breakdown Data by Type
    • 6.3 United States Metabotropic Glutamate Receptor (MRG) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Metabotropic Glutamate Receptor (MRG) Breakdown Data by Company
    • 7.2 European Union Metabotropic Glutamate Receptor (MRG) Breakdown Data by Type
    • 7.3 European Union Metabotropic Glutamate Receptor (MRG) Breakdown Data by Application

    8 China

    • 8.1 China Metabotropic Glutamate Receptor (MRG) Breakdown Data by Company
    • 8.2 China Metabotropic Glutamate Receptor (MRG) Breakdown Data by Type
    • 8.3 China Metabotropic Glutamate Receptor (MRG) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Metabotropic Glutamate Receptor (MRG) Breakdown Data by Company
    • 9.2 Rest of World Metabotropic Glutamate Receptor (MRG) Breakdown Data by Type
    • 9.3 Rest of World Metabotropic Glutamate Receptor (MRG) Breakdown Data by Application
    • 9.4 Rest of World Metabotropic Glutamate Receptor (MRG) Breakdown Data by Countries
      • 9.4.1 Rest of World Metabotropic Glutamate Receptor (MRG) Sales by Countries
      • 9.4.2 Rest of World Metabotropic Glutamate Receptor (MRG) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Addex Therapeutics (Switzerland)
      • 10.1.1 Addex Therapeutics (Switzerland) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Metabotropic Glutamate Receptor (MRG)
      • 10.1.4 Metabotropic Glutamate Receptor (MRG) Product Introduction
      • 10.1.5 Addex Therapeutics (Switzerland) Recent Development
    • 10.2 Domain Therapeutics (France)
      • 10.2.1 Domain Therapeutics (France) Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Metabotropic Glutamate Receptor (MRG)
      • 10.2.4 Metabotropic Glutamate Receptor (MRG) Product Introduction
      • 10.2.5 Domain Therapeutics (France) Recent Development
    • 10.3 Medgenics (USA)
      • 10.3.1 Medgenics (USA) Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Metabotropic Glutamate Receptor (MRG)
      • 10.3.4 Metabotropic Glutamate Receptor (MRG) Product Introduction
      • 10.3.5 Medgenics (USA) Recent Development
    • 10.4 Prexton Therapeutics (Switzerland)
      • 10.4.1 Prexton Therapeutics (Switzerland) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Metabotropic Glutamate Receptor (MRG)
      • 10.4.4 Metabotropic Glutamate Receptor (MRG) Product Introduction
      • 10.4.5 Prexton Therapeutics (Switzerland) Recent Development
    • 10.5 Taisho Pharmaceutical Holding (Japan)
      • 10.5.1 Taisho Pharmaceutical Holding (Japan) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Metabotropic Glutamate Receptor (MRG)
      • 10.5.4 Metabotropic Glutamate Receptor (MRG) Product Introduction
      • 10.5.5 Taisho Pharmaceutical Holding (Japan) Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Metabotropic Glutamate Receptor (MRG) Sales Channels
      • 11.2.2 Metabotropic Glutamate Receptor (MRG) Distributors
    • 11.3 Metabotropic Glutamate Receptor (MRG) Customers

    12 Market Forecast

    • 12.1 Global Metabotropic Glutamate Receptor (MRG) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Type
    • 12.3 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Application
    • 12.4 Metabotropic Glutamate Receptor (MRG) Forecast by Regions
      • 12.4.1 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
      In 2019, the market size of Metabotropic Glutamate Receptor (MRG) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Metabotropic Glutamate Receptor (MRG).

      This report studies the global market size of Metabotropic Glutamate Receptor (MRG), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Metabotropic Glutamate Receptor (MRG) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Addex Therapeutics (Switzerland)
      Domain Therapeutics (France)
      Medgenics (USA)
      Prexton Therapeutics (Switzerland)
      Taisho Pharmaceutical Holding (Japan)
      ...

      Market Segment by Product Type
      mGluR2
      mGluR4
      mGluR5

      Market Segment by Application
      Meningitis
      Septicemia
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Metabotropic Glutamate Receptor (MRG) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Metabotropic Glutamate Receptor (MRG) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Metabotropic Glutamate Receptor (MRG) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now